BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6420450)

  • 1. Investigation of human T-cell biology with monoclonal antibodies.
    Kung PC
    J Cutan Pathol; 1983 Dec; 10(6):457-66. PubMed ID: 6420450
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte subsets and surface molecules in man.
    Krensky AM; Lanier LL; Engleman EG
    Clin Immunol Rev; 1985; 4(1):95-138. PubMed ID: 2992859
    [No Abstract]   [Full Text] [Related]  

  • 3. Production and characterization of monoclonal antibodies to guinea pig lymphoid differentiation antigens.
    Chiba J; Chused TM; Leiserson WM; Zweig SE; Shevach EM
    J Immunol Methods; 1983 Oct; 63(2):247-61. PubMed ID: 6413591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin-dependent cellular cytotoxicity by human lymphocytes is blocked by monoclonal antibodies to the sheep red cell receptor.
    Görög G; Laskay T; Petrányi GG
    Immunol Lett; 1985; 11(2):107-9. PubMed ID: 3936780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.
    Bentin J; Carson DA; Vaughan JH; Tsoukas CD
    Transplantation; 1986 Sep; 42(3):317-20. PubMed ID: 3092413
    [No Abstract]   [Full Text] [Related]  

  • 6. [Regulation of human autologous mixed lymphocyte reactions by monoclonal antibodies directed at T cell differentiation antigens].
    Takada S; Sakane T; Suzuki N; Ueda Y; Murakawa Y; Tsunematsu T
    Arerugi; 1985 Jul; 34(7):442-9. PubMed ID: 2933012
    [No Abstract]   [Full Text] [Related]  

  • 7. The differential effects of distinct cytolysis-inhibiting monoclonal antibodies on growth and on cytolytic activity of T cell clones.
    Schmitt-Verhulst AM; Golstein P; Buferne M; Pierres M
    Adv Exp Med Biol; 1982; 146():521-32. PubMed ID: 6980573
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibody defines human cell surface protein p80 on intrathymic T cells.
    Haynes BF; Telen MJ; PalkerTJ ; Harden E; Scearce RM
    J Immunol; 1984 May; 132(5):2678. PubMed ID: 6425411
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal antibodies to tissue-associated antigens as antitumor reagents.
    Carroll AM; Zalutsky MR; Benacerraf B; Greene MI
    Surv Synth Pathol Res; 1984; 3(3):189-200. PubMed ID: 6436946
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
    Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
    Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative pathways for T lymphocyte activation.
    Shevach EM
    Prog Clin Biol Res; 1989; 288():127-40. PubMed ID: 2566174
    [No Abstract]   [Full Text] [Related]  

  • 12. Target antigen of monoclonal reagent S5.7: comparison with T3 antigen.
    Borst J; Spits H; de Vries J; Pessano S; Rovera G; Terhorst C
    Hybridoma; 1983; 2(3):265-74. PubMed ID: 6236145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of the LFA-1 and T4 molecules in the direct activation of resting human B lymphocytes by T lymphocytes.
    Tedder TF; Schmidt RE; Rudd CE; Kornacki MM; Ritz J; Schlossman SF
    Eur J Immunol; 1986 Dec; 16(12):1539-43. PubMed ID: 3102246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human T lymphocyte function with monoclonal antibodies.
    Dongworth DW; McMichael AJ
    Br Med Bull; 1984 Jul; 40(3):254-61. PubMed ID: 6205713
    [No Abstract]   [Full Text] [Related]  

  • 15. The significance of T-cell subsets defined by monoclonal antibodies in human diseases.
    Bach JF; Chatenoud L
    Ann Immunol (Paris); 1982; 133D(2):131-6. PubMed ID: 6187268
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4.
    Eichmann K; Jönsson JI; Falk I; Emmrich F
    Eur J Immunol; 1987 May; 17(5):643-50. PubMed ID: 3108015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysis of autologous Epstein-Barr virus-infected B cells by cytotoxic T lymphocytes of rheumatoid arthritis patients.
    Tsoukas CD; Carson DA; Fong S; Slovin SF; Fox RI; Vaughan JH
    Clin Immunol Immunopathol; 1982 Jul; 24(1):8-14. PubMed ID: 6179673
    [No Abstract]   [Full Text] [Related]  

  • 18. Difficulties and new strategies in the identification of functional T cell populations in humans.
    Moretta A; Mingari MC; Pantaleo G; Melioli G; Moretta L
    Monogr Allergy; 1983; 18():106-11. PubMed ID: 6417476
    [No Abstract]   [Full Text] [Related]  

  • 19. T cell activation via cell-surface antigens other than the CD3/T cell receptor complex.
    Yokoyama WM; Shevach EM
    Year Immunol; 1989; 4():110-46. PubMed ID: 2467458
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of two monoclonal antibodies against chicken T lymphocyte surface antigens.
    Vainio O; Veromaa T; Eerola E; Toivanen P
    Prog Clin Biol Res; 1987; 238():99-108. PubMed ID: 3110793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.